MAGE-B17 activators encompass a diverse array of chemical compounds that augment the protein's functional activity via distinct biochemical pathways. One such activator directly stimulates adenylate cyclase, thereby escalating cyclic AMP levels, which in turn may invigorate MAGE-B17 by fostering cAMP-dependent protein kinase signaling. This cascade effect can culminate in the enhanced functionality of MAGE-B17 by modifying the expression and activity of genes within its regulatory network. Other activators operate through epigenetic mechanisms, such as the inhibition of DNA methyltransferases and histone deacetylases, which can lead to chromatin remodeling. This epigenetic modulation potentially heightens the transcription of specific genes, including MAGE-B17, thereby facilitating its activation by fostering a more transcriptionally conducive chromatin landscape.
Furthermore, activators that inhibit the degradation of cyclic nucleotides augment signaling pathways which might elevate MAGE-B17 activity. In parallel, compounds that modulate immune or stress response pathways can also contribute to the protein's activation, possibly through the alteration of gene expression. The involvement of protein kinase C activation in these processes suggests additional routes by which MAGE-B17's activity could be upregulated. Additionally, certain activators leverage the critical role of cofactors and transcription factors in gene expression, potentially stabilizing protein-DNA complexes and thus enhancing the expression and function of MAGE-B17.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits DNA methyltransferases, which can lead to hypomethylation and the consequent activation of certain genes, potentially increasing MAGE-B17 expression as it may be epigenetically regulated. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that causes chromatin remodeling, potentially increasing the transcription of genes including the gene MAGE-B17 by promoting a more accessible chromatin state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into DNA and RNA, inhibiting DNA methyltransferases. This could result in the demethylation and activation of gene expression, potentially enhancing the expression of MAGE-B17. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can lead to an open chromatin conformation and potentially upregulate gene expression, including the gene MAGE-B17. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates sirtuin 1 (SIRT1), which may deacetylate proteins and affect gene expression, potentially leading to the increased activity of MAGE-B17 by modifying the expression of genes related to its functional pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibitor of NF-kappaB activation, which could lead to altered expression of genes and potentially enhance the activity of MAGE-B17 through modulation of immune or stress response pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could enhance the signaling pathways that involve MAGE-B17, leading to its functional activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences gene expression by activating retinoic acid receptors, potentially upregulating the expression of genes including MAGE-B17, thus enhancing its activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Functions as a cofactor for various enzymes and transcription factors, potentially enhancing the expression and function of MAGE-B17 by stabilizing proteins and DNA complexes. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that can interfere with hormone signaling, potentially affecting gene expression patterns including those of MAGE-B17 through estrogen receptor pathways. | ||||||